Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (561-570 of 934) with videos related to

Pageof 94
Sort By:
Journal of Lipid Research|November 23, 2012
Measurement of LDL-C after treatment with the CETP inhibitor anacetrapibMichael Davidson, Sherry Xueyu Liu, Philip Barter, et al.
JAMA|October 24, 2013
Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysisJacob A Udell, Rami Zawi, Deepak L Bhatt, et al.
Circulation|December 28, 2018
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME TrialDavid Fitchett, Silvio E Inzucchi, Christopher P Cannon, et al.
JAMA|September 7, 2005
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY studyMarc S Sabatine, Christopher P Cannon, C Michael Gibson, et al.
JAMA|June 16, 2005
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trialsShamir R Mehta, Christopher P Cannon, Keith A A Fox, et al.
Circulation|April 17, 2002
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptideMarc S Sabatine, David A Morrow, James A de Lemos, et al.
The American Journal of Cardiology|October 29, 2005
Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial)Jocelyn Dupuis, Jean-Claude Tardif, Jean-Lucien Rouleau, et al.
American Heart Journal|May 16, 2016
Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trialYuichi J Shimada, Christopher P Cannon, Yuyin Liu, et al.
Clinical Cardiology|June 15, 2021
Kidney outcomes using a sustained ≥40% decline in eGFR: A meta-analysis of SGLT2 inhibitor trialsDavid Z I Cherney, Samuel Dagogo-Jack, Darren K McGuire, et al.
Sleep & Breathing = Schlaf & Atmung|May 20, 2022
Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trialBrian S Wojeck, Silvio E Inzucchi, Ian J Neeland, et al.
Pageof 94

Showing results (561-570 of 934) with videos related to

Sort By:
Pageof 94
Journal of Lipid Research|November 23, 2012
Measurement of LDL-C after treatment with the CETP inhibitor anacetrapibMichael Davidson, Sherry Xueyu Liu, Philip Barter, et al.
JAMA|October 24, 2013
Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysisJacob A Udell, Rami Zawi, Deepak L Bhatt, et al.
Circulation|December 28, 2018
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME TrialDavid Fitchett, Silvio E Inzucchi, Christopher P Cannon, et al.
JAMA|September 7, 2005
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY studyMarc S Sabatine, Christopher P Cannon, C Michael Gibson, et al.
JAMA|June 16, 2005
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trialsShamir R Mehta, Christopher P Cannon, Keith A A Fox, et al.
Circulation|April 17, 2002
Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptideMarc S Sabatine, David A Morrow, James A de Lemos, et al.
The American Journal of Cardiology|October 29, 2005
Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial)Jocelyn Dupuis, Jean-Claude Tardif, Jean-Lucien Rouleau, et al.
American Heart Journal|May 16, 2016
Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trialYuichi J Shimada, Christopher P Cannon, Yuyin Liu, et al.
Clinical Cardiology|June 15, 2021
Kidney outcomes using a sustained ≥40% decline in eGFR: A meta-analysis of SGLT2 inhibitor trialsDavid Z I Cherney, Samuel Dagogo-Jack, Darren K McGuire, et al.
Sleep & Breathing = Schlaf & Atmung|May 20, 2022
Ertugliflozin and incident obstructive sleep apnea: an analysis from the VERTIS CV trialBrian S Wojeck, Silvio E Inzucchi, Ian J Neeland, et al.
Pageof 94